← 返回

非典型记忆 B 细胞在肝细胞癌中获得 Breg 表型

英文原题:Atypical memory B cells acquire Breg phenotypes in hepatocellular carcinoma.

查看英文原题

Atypical memory B cells acquire Breg phenotypes in hepatocellular carcinoma.

PubMed 2025/02/25(内容时间) JCI Insight Q1 · IF 6.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

TIL(肿瘤浸润淋巴细胞)B细胞(TIL-B)的功能可塑性涵盖从抗肿瘤反应到非经典免疫抑制。然而,肿瘤微环境(TME)如何影响TIL-B的发育仍被低估。

我们当前的研究整合了单细胞转录组学和B细胞受体(BCR)测序,以分析肝细胞癌(HCC)中TIL-B的表型和克隆性。利用轨迹和基因调控网络分析,我们能够表征HCC TME中的浆细胞以及记忆和初始B细胞,并进一步揭示了浆细胞和一部分炎症性TNF+记忆B细胞中BCR信号基因的下调。在TME中,一个非类别转换记忆B细胞亚群获得了年龄相关B细胞表型(TBET+CD11c+),并表达更高水平的PD-L1、CD25和颗粒酶B。

我们进一步证明,HCC肿瘤细胞的存在可赋予外周血B细胞抑制功能,进而削弱T细胞共刺激。据我们所知,这些发现代表了HCC中非经典免疫抑制的新机制。虽然先前的研究在慢性肝炎和多种实体癌类型中发现了非典型记忆B细胞,但我们进一步强调了它们在HCC患者的TME和外周血中作为调节性B细胞(Bregs)的潜在作用。

展开英文摘要原文

The functional plasticity of tumor-infiltrating lymphocyte B-cells (TIL-B) spans from antitumor responses to noncanonical immune suppression. Yet, how the tumor microenvironment (TME) influences TIL-B development is still underappreciated.

Our current study integrated single-cell transcriptomics and B cell receptor (BCR) sequencing to profile TIL-B phenotypes and clonalities in hepatocellular carcinoma (HCC).

Using trajectory and gene regulatory network analysis, we were able to characterize plasma cells and memory and naive B cells within the HCC TME and further revealed a downregulation of BCR signaling genes in plasma cells and a subset of inflammatory TNF+ memory B cells. Within the TME, a nonswitched memory B cell subset acquired an age-associated B cell phenotype (TBET+CD11c+) and expressed higher levels of PD-L1, CD25, and granzyme B.

We further demonstrated that the presence of HCC tumor cells could confer suppressive functions on peripheral blood B cells that in turn, dampen T cell costimulation. To the best of our knowledge, these findings represent novel mechanisms of noncanonical immune suppression in HCC. While previous studies identified atypical memory B cells in chronic hepatitis and across several solid cancer types, we further highlighted their potential role as regulatory B cells (Bregs) within both the TME and peripheral blood of HCC patients.

论文信息

作者
Neo SY、Shuen TWH、Khare S、Chong J、Lau M、Shirgaonkar N、Chua L、Zhao J
单位
Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore.Singapore
文献类型
非美国政府资助研究
期刊
JCI insight2025 Feb 25
原文标识
PubMed 39998891 · DOI 10.1172/jci.insight.187025